Understanding the Increased Risk of Atrial Fibrillation in Athletes: a Case-control Study

NCT ID: NCT06844656

Last Updated: 2025-02-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-28

Study Completion Date

2026-10-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Exercise is beneficial to heart health, however, there appears to be a 'U' shaped relationship where too much exercise may increase the risk of an irregular heart rhythm, called atrial fibrillation. Endurance athletes may have up to a 2.5-fold higher risk of developing atrial fibrillation than non-athletic controls.

The mechanisms behind this increased risk of atrial fibrillation are not the well understood. It is thought to be a mixture of enlarged heart chambers, low resting heart rate, genetic predisposition and possibly scarring in the heart. In this study, the investigators will investigate the electrical activity changes in the heart, using a high-quality electrocardiogram (ECG) and relate this to changes in the heart size measured by ultrasound and MRI. Cardiopulmonary exercise testing will determine fitness (V̇O2 max) and assess the heart's electrical activity during exercise.

This will be a case-control study where athletes with and without atrial fibrillation will be recruited. The investigators hope the results of this study can improve our understanding of atrial fibrillation in athletes by associating atrial fibrillation with structural and electrical differences which may aid the prediction of future atrial fibrillation development and help guide more athlete-specific treatment pathways.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation (AF)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AF Athletes

Athletes with atrial fibrillation.

No interventions assigned to this group

Non-AF Athletes

Athletes without atrial fibrillation.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥18 years of age at the time of enrolment, male and female.
* History of atrial fibrillation confirmed on ECG - either paroxysmal or persistent.
* Competitive athlete. Defined as:

1. Competed in endurance sports with a total cumulative moderate to high intensity of \> 1500 hours.
2. Have participated in at least one competitive event in the last 10 years.

Exclusion Criteria

* Permanent atrial fibrillation.
* History of pre-existing cardiovascular disease :

1. Atherosclerotic disease: previous myocardial infarction, symptomatic coronary artery disease or Peripheral peripheral arterial disease
2. Left ventricular systolic dysfunction (EF \< 45%)
3. Heart muscle disease: cardiomyopathies, Infiltrative diseases of the heart
4. Complex Congenital heart disease
5. Moderate or severe valvular disease
6. Uncontrolled hypertension (\>180/100mmHg)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Leicester

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Cardiovascular Sciences. University of Leicester. Glenfield Hospital.

Leicester, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cai L Davies

Role: CONTACT

+447765791818

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cai L Davies

Role: primary

+447765791818

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise Effects on Atrial Fibrillation
NCT06607510 NOT_YET_RECRUITING NA
Exercise Training to Atrial Fibrillation
NCT04508478 ACTIVE_NOT_RECRUITING NA